Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.
about
MBX-102/JNJ39659100, a novel non-TZD selective partial PPAR-γ agonist lowers triglyceride independently of PPAR-α activationPPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertaintyAtherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazoneThe current role of thiazolidinediones in diabetes management.Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL.In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist.Activation of peroxisome proliferator activated receptor-gamma results in an atheroprotective apolipoprotein profile in HepG2 cells.Effect of pioglitazone treatment on endoplasmic reticulum stress response in human adipose and in palmitate-induced stress in human liver and adipose cell lines.PPARdelta Agonism for the Treatment of Obesity and Associated Disorders: Challenges and OpportunitiesPeroxisome proliferator-activated receptors and hepatitis C virus-induced insulin resistancePleiotropic effects of thiazolidinediones.Peroxisome proliferator-activated receptor agonists: do they increase cardiovascular risk?Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?Effect of urotensin II on apolipoprotein B100 and apolipoprotein A-I expression in HepG2 cell lineThree-dimensional perfused human in vitro model of non-alcoholic fatty liver disease.Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells.Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.Effects of Low-Dose Pioglitazone on Serum Levels of Adiponectin, Dehydroepiandrosterone, Amyloid Beta Peptide, and Lipid Profile in Elderly Japanese People with Type 2 Diabetes
P2860
Q21342745-08B06205-BECD-491A-B5F4-AB6EBCE2FCE0Q27024799-25D09A79-61CD-4004-ABA3-4BB7747E1365Q28512042-62D346D3-15BD-477C-B848-2571537A8F70Q30250347-F1EB0961-4A36-4AFA-B19F-C7D29CB36B4FQ34395184-F48ECD0D-364C-40FB-B518-9331C1A0067BQ36363679-C77E85A7-267F-4C3C-B513-AC5D27E8F1CDQ36783555-89087887-9689-4216-A667-8D0CCAA61842Q36846138-46C23F80-0D0F-4297-A21B-9B7CACCB15B7Q36959065-9B805F00-A3CE-43C6-902B-C0A5F7B47459Q37037509-3E210E9E-19FF-4FCF-8096-EE5647113147Q37142044-6707477D-FDF6-4215-B96F-1D66A3F016D4Q37583596-D59047B2-2AD3-4069-8BD8-AA9E0A67D919Q38092275-92668268-87C7-4041-8C2E-8ECE0E64C1B5Q39018162-0484D72B-95BF-41AD-B82C-7C5D0180B315Q39140524-1CEB3544-A83F-460B-916E-9FEF45FE24C3Q41831875-84031286-CA8D-4F07-8B01-626D750D3F68Q46024732-4C656E12-7CB0-4098-A40B-998C89797BDAQ59101872-C2CFDE10-446F-4283-BB23-682F4199CC5F
P2860
Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pioglitazone stimulates apolip ...... ls: involvement of PPAR-alpha.
@en
type
label
Pioglitazone stimulates apolip ...... ls: involvement of PPAR-alpha.
@en
prefLabel
Pioglitazone stimulates apolip ...... ls: involvement of PPAR-alpha.
@en
P2093
P1476
Pioglitazone stimulates apolip ...... ls: involvement of PPAR-alpha.
@en
P2093
Moti L Kashyap
Shucun Qin
Tianjiao Liu
Vaijinath S Kamanna
P304
P356
10.1161/ATVBAHA.107.150193
P407
P577
2007-09-13T00:00:00Z